Inhibition of post-transcriptional RNA processing by CDK inhibitors and its implication in anti-viral therapy.
Cyclin-dependent kinases (CDKs) are key regulators of the cell cycle and RNA polymerase II mediated transcription. Several pharmacological CDK inhibitors are currently in clinical trials as potential cancer therapeutics and some of them also exhibit antiviral effects. Olomoucine II and roscovitine,...
Saved in:
| Main Authors: | Jitka Holcakova, Petr Muller, Peter Tomasec, Roman Hrstka, Marta Nekulova, Vladimir Krystof, Miroslav Strnad, Gavin W G Wilkinson, Borivoj Vojtesek |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0089228 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUMOylation is not a prerequisite for HSF1’s role in stress protection and transactivation
by: Miroslav Bardelcik, et al.
Published: (2025-07-01) -
Olomoucine II, New Effective CDK Inhibitor with Strong Cytotoxic Properties
by: R. Lenobel, et al.
Published: (2001-01-01) -
Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties
by: Martin Krkoška, et al.
Published: (2025-07-01) -
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
by: Marta Buzzetti, et al.
Published: (2021-03-01) -
Multitarget CDK inhibitors roscovitine and UCN‑01 induce apoptosis in colorectal cancer cells by inhibiting cell cycle progression and transcription
by: Sonal Mohan Manohar, et al.
Published: (2025-01-01)